Concepedia

Qi-Peng Shu

QS

Statistics

Publications

4

Citations

124

H-Index

4

Active since

2018

Affiliations

Hubei University(Current)

Wuhan University

Zhongnan Hospital of Wuhan University

Hunan Normal University

Chongqing University

Qi-Peng Shu is an author at Hubei University specializing in molecular biology, medicine, and inflammatory cytokine production.

ORCID

Publications per year

2018–2024

4

Publications

4

Phosphorylation of MAVS/VISA by Nemo-like kinase (NLK) for degradation regulates the antiviral innate immune response

Shangze Li, Qi-Peng Shu, Yang Song et al. · Nature Communications · 2019 · 59 citations · Full text

, , +17

Nemo-like kinase (NLK) primes colorectal cancer progression by releasing the E2F1 complex from HDAC1

Shangze Li, Feng Zeng, ­Jun Li­ et al. · Cancer Letters · 2018 · 36 citations

, , +10

Activation of CTNNB1 by deubiquitinase UCHL3-mediated stabilization facilitates bladder cancer progression

Tao Liu, Mengqi Fan, Xiaoxiao Xie et al. · Journal of Translational Medicine · 2023 · 16 citations · Full text

, , +16

CLK2 mediates IκBα-independent early termination of NF-κB activation by inducing cytoplasmic redistribution and degradation

Shangze Li, Qi-Peng Shu, Hai‐Meng Zhou et al. · Nature Communications · 2024 · 13 citations · Full text

, , +17

1–4 of 4